Serum Cholesterol Levels in Neutropenic Patients with Fever
-
Peter Fraunberger
Abstract
Hypocholesterolemia, which often accompanies infectious diseases has been suggested to serve as a prognostic marker in hospitalized patients. Even though patients with chemotherapy-induced leukopenia are at high risk of infection and mortality, only limited information is available on serum cholesterol levels in these patients. We therefore measured serum cholesterol levels in 17 patients with hematological malignancies during chemotherapy-induced neutropenia and correlated it with clinical outcome. Patients with fever (>38.5 °C) showed a significant decrease in serum cholesterol levels within 24 hours. Eight days after onset of the fever non-survivors had significantly lower serum cholesterol levels (median 2.09 mmol/l, range 0.49–2.79, n=6) compared to survivors (median 3.23 mmol/l, range 1.68–4.86, n=11). Cholesterol levels in survivors returned to baseline levels at the time of discharge from the hospital. At the onset of fever, serum levels of inflammatory cytokines interleukin-6, tumor necrosis factor (TNF) and soluble TNF receptors p55 and p75 were elevated in all patients, but only TNF and TNF receptor p75 levels were significantly different in survivors and non-survivors.
Our data suggest that a decrease in serum cholesterol levels is a prognostic marker in neutropenic patients with fever. Release of inflammatory cytokines may in part be responsible for hypocholesterolemia in these patients.
Copyright © 2002 by Walter de Gruyter GmbH & Co. KG
Artikel in diesem Heft
- New Developments in Clinical Chemistry and Laboratory Medicine as Documented by EUROMEDLAB 2001 the 14th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Prague, May 2631, 2001
- Haptoglobin Polymorphism and Body Iron Stores
- Immunohistochemistry in the Evaluation of Spermatogenesis and Sertoli Cell's Maturation Status
- Study of Therapy Resistance in Cancer Cells with Functional Proteome Analysis
- Proposition of an Aging Indicator from General Health Examination in France
- Comparison of Plasma Cardiac Troponins T and I in Chronically Hemodialyzed Patients in Relation to Cardiac Status and Age
- Medical and Economic Outcomes of Point-of-Care Testing
- Are Laboratory Investigations Recommended in Current Medical Practice Guidelines Supported by Available Evidence?
- New Aspects on Angiotensin-Converting Enzyme: from Gene to Disease
- Oxypurines, Protein, Glucose and the Functional State of Blood Vasculature Are Markers of Renal Calcium Stone-forming Processes? Observations in Men with Idiopathic Recurrent Calcium Urolithiasis
- Long-Chain Polyunsaturated Fatty Acids in Rat Maternal Milk, Offspring Brain and Peripheral Tissues in Essential Fatty Acid Deficiency
- Simultaneous Quantification of Sirolimus, Everolimus, Tacrolimus and Cyclosporine by Liquid Chromatography-Mass Spectrometry (LC-MS)
- Pancreatic Phospholipase A2 Activity in Acute Pancreatitis: a Prognostic Marker for Early Identification of Patients at Risk
- Serum Cytokeratin Fragment 21.1 (CYFRA 21.1) as Tumour Marker for Breast Cancer: Comparison with Carbohydrate Antigen 15.3 (CA 15.3) and Carcinoembryonic Antigen (CEA)
- Serum Cholesterol Levels in Neutropenic Patients with Fever
- Evaluation of Two Mg2+-Selective Electrodes by Means of a Flow-Through Device
- The Management of Clinical Laboratories in Europe: a FESCC Survey
- Meetings and Awards
Artikel in diesem Heft
- New Developments in Clinical Chemistry and Laboratory Medicine as Documented by EUROMEDLAB 2001 the 14th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Prague, May 2631, 2001
- Haptoglobin Polymorphism and Body Iron Stores
- Immunohistochemistry in the Evaluation of Spermatogenesis and Sertoli Cell's Maturation Status
- Study of Therapy Resistance in Cancer Cells with Functional Proteome Analysis
- Proposition of an Aging Indicator from General Health Examination in France
- Comparison of Plasma Cardiac Troponins T and I in Chronically Hemodialyzed Patients in Relation to Cardiac Status and Age
- Medical and Economic Outcomes of Point-of-Care Testing
- Are Laboratory Investigations Recommended in Current Medical Practice Guidelines Supported by Available Evidence?
- New Aspects on Angiotensin-Converting Enzyme: from Gene to Disease
- Oxypurines, Protein, Glucose and the Functional State of Blood Vasculature Are Markers of Renal Calcium Stone-forming Processes? Observations in Men with Idiopathic Recurrent Calcium Urolithiasis
- Long-Chain Polyunsaturated Fatty Acids in Rat Maternal Milk, Offspring Brain and Peripheral Tissues in Essential Fatty Acid Deficiency
- Simultaneous Quantification of Sirolimus, Everolimus, Tacrolimus and Cyclosporine by Liquid Chromatography-Mass Spectrometry (LC-MS)
- Pancreatic Phospholipase A2 Activity in Acute Pancreatitis: a Prognostic Marker for Early Identification of Patients at Risk
- Serum Cytokeratin Fragment 21.1 (CYFRA 21.1) as Tumour Marker for Breast Cancer: Comparison with Carbohydrate Antigen 15.3 (CA 15.3) and Carcinoembryonic Antigen (CEA)
- Serum Cholesterol Levels in Neutropenic Patients with Fever
- Evaluation of Two Mg2+-Selective Electrodes by Means of a Flow-Through Device
- The Management of Clinical Laboratories in Europe: a FESCC Survey
- Meetings and Awards
